Structural reform and diagnostics and life sciences growth under the Medium-Term Management Plan 2027 and 2030 Vision

A theme in which 6523 pursues phased, sustainable growth centred on diagnostics and life sciences under its Medium-Term Management Plan 2027 and 2030 Vision, together with structural reforms through cost reductions, organisational restructuring, working-capital improvements, selective investment, and ROIC management.